1.
ClinicalTrials.gov; 16/08/2023; TrialID: NCT05996770
Clinical Trial Register
| ICTRP | ID: ictrp-NCT05996770
ABSTRACT
Condition:
Paxlovid;Azvudine;COVID-19Primary outcome:
mortalityCriteria:
Inclusion Criteria:
- 1. The patient's admission time is from December 1,2022 to January 31,2023. 2. The
patient has used either Paxlovid or azivudine tablets during admission. 3. Age = 18
years old. Exclusion Criteria:
- 1. Patients using other antiviral drugs. 2. Patients with incomplete clinical data.